Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017;138(1):1-8.
doi: 10.1159/000471846. Epub 2017 May 13.

First-Line Support by Intra-Aortic Balloon Pump in Non-Ischaemic Cardiogenic Shock in the Era of Modern Ventricular Assist Devices

Affiliations

First-Line Support by Intra-Aortic Balloon Pump in Non-Ischaemic Cardiogenic Shock in the Era of Modern Ventricular Assist Devices

Corstiaan A den Uil et al. Cardiology. 2017.

Abstract

Objectives: Little is known about circulatory support in cardiogenic shock (CS) from other causes than the acute coronary syndrome or after cardiotomy. We evaluated the effects of first-line intra-aortic balloon pump (IABP) support in this subpopulation of CS patients.

Methods: A retrospective study was performed in 27 patients with CS from end-stage cardiomyopathy supported firstly by IABP in the years 2011-2016.

Results: At 24 h, lactate decreased from 3.2 (2.1-6.8) to 1.8 (1.2-2.2) mmol/L (p < 0.001). Eighteen patients (67%) defined as IABP responders were successfully bridged to either recovery (n = 7), left ventricular assist device (n = 5), or heart transplantation (n = 6). IABP failed in 9 patients (non-responders, 33%) who either died (n = 7) or needed support by extracorporeal membrane oxygenation (n = 2). At 24 h of IABP support, urinary output was higher (2,660 [1,835-4,440] vs. 1,200 [649-2,385] mL; p = 0.02) and fluid balance more negative (-1,564 [-2,673 to -1,086] vs. -500 [-930 to +240] mL; p < 0.001) in responders than non-responders. Overall survival at 1 year was 63%.

Conclusion: In most patients, first-line support by IABP in end-stage cardiomyopathy is associated with improvement in organ perfusion and clinical stabilisation for at least 24 h allowing time for decision making on next therapies.

Keywords: Cardiogenic shock; Cardiomyopathy; End-stage heart failure; Intra-aortic balloon pump; Mechanical circulatory support.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Distribution of indications for intra-aortic balloon pump in our Centre. AMI, acute myocardial infarction; PCI, percutaneous coronary intervention.
Fig. 2
Fig. 2
Flow chart of outcomes. ECMO, extracorporeal membrane oxygenation; HTx, heart transplantation; IABP, intra-aortic balloon pump; LVAD, left ventricular assist device.
Fig. 3
Fig. 3
Box-and-whiskers plots of changes in mean arterial pressure (a), central venous pressure (b), 24-h urinary production (c), and 24-h fluid balance (d). Boxes indicate interquartile ranges and whiskers minimum and maximum values. □, IABP responders; ■, IABP non-responders. * p < 0.05, ** p < 0.01.
Fig. 4
Fig. 4
Kaplan-Meier survival curve of the study population versus patients on intra-aortic balloon pump for shock from acute myocardial infarction (AMI) and predicted survival according to the HeartMate II risk score.

Comment in

References

    1. Mebazaa A, Tolppanen H, Mueller C, et al. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive Care Med. 2016;42:147–163. - PubMed
    1. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol (Engl Ed) 2016;69:1167. - PubMed
    1. Kar B, Basra SS, Shah NR, Loyalka P. Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery. Circulation. 2012;125:1809–1817. - PubMed
    1. Santa-Cruz RA, Cohen MG, Ohman EM. Aortic counterpulsation: a review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv. 2006;67:68–77. - PubMed
    1. Thiele H, Zeymer U, Werdan K. Intraaortic balloon support for cardiogenic shock. N Engl J Med. 2013;368:81. - PubMed

MeSH terms